Regeneron Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • ID: 2343300
  • Mergers and Acquisitions Profiles
  • 99 pages
  • MarketLine
  • Regeneron Pharmaceuticals Inc
1 of 3
Regeneron Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary

This Regeneron Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Regeneron Pharmaceuticals, Inc. since January2007.

Synopsis

This Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Regeneron Pharmaceuticals, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Regeneron Pharmaceuticals, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope
  • Provides intelligence on Regeneron Pharmaceuticals, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
  • Detailed reports of various financial transactions undertaken by Regeneron Pharmaceuticals, Inc. and its subsidiaries since 2007.
  • Information about key financial and legal advisors for Regeneron Pharmaceuticals, Inc.'s financial deals transactions.
  • Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Reasons to buy
  • Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
  • Form an independent opinion about Regeneron Pharmaceuticals, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
  • Track your competitors’ business structure and growth strategies.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
COMPANY OVERVIEW AND KEY FACTS

TARGETS AND PARTNERS

CORPORATE VENTURING
Corporate Venturing - Overview
Corporate Venturing - Deal reports

PARTNERSHIP
Partnership - Overview
Partnership - Deal reports

CAPITAL RAISING
Capital Raising - Deal reports

APPENDIX

Contact Us
About Financial Deals Database
Deal Definition and Methodology
About the Publisher

List of Tables
Table 1: Regeneron Pharmaceuticals corporate venturing volume and value trend (2013-YTD2017)
Table 2: Regeneron Pharmaceuticals corporate venturing by geography (2013-YTD2017)
Table 3: Regeneron Pharmaceuticals partnership volume and value trend (2013-YTD2017)
Table 4: Regeneron Pharmaceuticals partnership trend by key deal type (2013-YTD2017)

List of Figures
Figure 1: Regeneron Pharmaceuticals corporate venturing volume and value trend (2013-YTD2017)
Figure 2: Regeneron Pharmaceuticals corporate venturing by geography (2013-YTD2017)
Figure 3: Regeneron Pharmaceuticals partnership volume and value trend (2013-YTD2017)
Figure 4: Regeneron Pharmaceuticals partnership trend by key deal type (2013-YTD2017)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll